NEOS Investment Management LLC Has $4.31 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

NEOS Investment Management LLC boosted its position in Colgate-Palmolive (NYSE:CL) by 30.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 47,398 shares of the company’s stock after purchasing an additional 11,195 shares during the period. NEOS Investment Management LLC’s holdings in Colgate-Palmolive were worth $4,309,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of CL. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $26,000. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Briaud Financial Planning Inc acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Finally, Wintrust Investments LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $33,000. Institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on the company. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday. Barclays raised their price target on shares of Colgate-Palmolive from $83.00 to $89.00 and gave the stock an “equal weight” rating in a research report on Thursday. TD Cowen cut their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the stock an “overweight” rating in a report on Friday, March 14th. Finally, UBS Group cut their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $102.06.

Colgate-Palmolive Stock Performance

NYSE CL opened at $93.25 on Friday. The company has a market cap of $75.68 billion, a P/E ratio of 26.49, a PEG ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The company has a fifty day simple moving average of $89.62 and a 200 day simple moving average of $93.80.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the firm earned $0.87 earnings per share. Sell-side analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.23%. The ex-dividend date of this dividend is Thursday, April 17th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.50. Colgate-Palmolive’s payout ratio is 59.09%.

Colgate-Palmolive announced that its Board of Directors has approved a share buyback plan on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to purchase up to 6.8% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.